Equities

Haleon PLC

HLN:LSE

Haleon PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)372.40
  • Today's Change3.80 / 1.03%
  • Shares traded19.15m
  • 1 Year change13.88%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024 17:02 GMT.
More ▼

IC View

The last IC recommendation on Haleon PLC shares was Buy at 356.00 on 01 Aug 2024Read the full article

Key statistics

On Thursday, Haleon PLC (HLN:LSE) closed at 372.40, -7.05% below its 52-week high of 400.65, set on Sep 18, 2024.
52-week range
Today
308.37Mar 20 2024400.65Sep 18 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open369.70
High373.30
Low367.50
Bid350.00
Offer375.00
Previous close368.60
Average volume15.71m
Shares outstanding9.05bn
Free float8.08bn
P/E (TTM)17.50
Market cap33.37bn GBP
EPS (TTM)0.2106 GBP
Annual div (ADY)6.20 GBX
Annual div yield (ADY)1.68%
Div ex-dateAug 15 2024
Div pay-dateSep 19 2024
Data delayed at least 20 minutes, as of Nov 21 2024 17:02 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.